A Paired Double Blind Randomised Comparison of Cavilon Durable Barrier Cream (CDBC) to 10% Glycerine (“Sorbolene”) Cream in the Prophylactic Management of Post-Mastectomy Irradiation Skin Care.

Primary Sponsor

Trans-Tasman Radiation Oncology Group (TROG)

Clinical Trial Registration

Related Post

Myall Coast Veteran Golfers fundraiser for TROG
12 November, 2025

Veterans golf club swings behind TROG Cancer Research

LATEST NEWS: 12 November 2025 More than 100 golfers

SUPREMO breast cancer trial results published in NEJM
6 November, 2025

SUPREMO trial findings signal change in breast cancer treatment

LATEST NEWS: 6 November 2025 Radiotherapy can be safely